ipilimumab,nivolumab,cabozantinib
exelixis,bms
['thanks', 'rcc,(-irccs),(-srcc),(-urcc)', 'crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'pdigree']
a beautifully comprehensive discussion from on first line metastatic #kidneycancer thanks for highlighting our #pdigree trial &amp; molecular selection w #opticrcc! #esmo22 
I treat & research GU cancers @UTSW Dallas. Columbia/Harvard Med/Duke alum; Mom & wife Tweets=my opinions ASCO: https://t.co/Whk29PATXe